Combination of the gamma-glutamyltransferase-to-prealbumin ratio and other indicators may be a novel marker for predicting the prognosis of patients with hepatocellular carcinoma undergoing locoregional ablative therapies.
Qi WangP ZhaoN HeJ P SunK LiC R ZangY N ZhaoY ZhaoY H ZhangPublished in: Infectious agents and cancer (2019)
Fib-GPR and N-GPR scores may be helpful in predicting both recurrence and the prognosis of HCC patients, thereby assisting in the process to make a true clinical decision and optimize therapeutic options.